Related Experiment Video
Updated: Oct 15, 2025
Author Spotlight: Advancing Thymic Epithelial Cells and T-Cell Research with Human Thymic Organoids
Published on: October 4, 2024
Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus
Rafael Gras-Peña1, Nichole M Danzl2, Mohsen Khosravi-Maharlooei2
1Columbia Center for Human Development, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY; Columbia Center for Translational Immunology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Researchers generated human thymic epithelial progenitors (hES-TEPs) from stem cells, demonstrating their ability to support T-cell development in vivo. This breakthrough offers potential therapies for thymic insufficiency by creating functional thymic tissue.
Area of Science:
- Stem cell biology and regenerative medicine.
- Immunology and developmental biology.
- Tissue engineering for therapeutic applications.
Background:
- Acquired and congenital thymic insufficiency states require novel therapeutic strategies.
- Generation of functional thymic tissue from pluripotent stem cells is a key goal for treating these conditions.
Purpose of the Study:
- To generate human thymic epithelial progenitors (hES-TEPs) from human embryonic stem cells.
- To assess the in vivo thymopoietic function of these generated hES-TEPs.
Main Methods:
- hES-TEPs were differentiated using developmental cues (FGF8, retinoic acid, SHH, Noggin, BMP4).
- Function was assessed in reaggregate grafts and hybrid swine thymus (SwTHY) models in immunodeficient mice receiving human hematopoietic stem and progenitor cells (hHSPCs).
Main Results:
- Differentiated hES-TEPs expressed key thymic epithelial cell markers (FOXN1, EPCAM).
- hES-TEPs supported human T-cell development in vivo, particularly within the SwTHY hybrid model.
- Integration into SwTHY grafts enhanced thymopoiesis and increased peripheral CD4+ naive T-cell reconstitution.
Conclusions:
- A novel protocol successfully generated hES-TEPs with demonstrated in vivo thymopoietic function.
- The SwTHY hybrid thymus model effectively supports and enhances human thymocyte development, showing promise for future therapies.
